Ipilimumab vs Lorazepam

## Ipilimumab vs Lorazepam: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Lorazepam**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Lorazepam**: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Lorazepam — 10-20 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Lorazepam — C15H10Cl2N2O2.

**Molecular Weight**: Ipilimumab — N/A; Lorazepam — 321.1580 g/mol.

**Type**: Ipilimumab — Antibody; Lorazepam — Small molecule.